患有癌症的青少年和年轻成年人中使用大麻:一个范围广泛的审查
Laura C Schubel1,2, Darcey M McCready3, Cassidy R LoParco3
1Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA. lschubel@gwu.edu.
概括
患有癌症史的年轻人使用大麻用于疼痛和恶心等医疗原因. 需要对他们的非医疗大麻使用模式进行更多研究.
科学领域:
- 在瘤学瘤学.
- 大麻研究 大麻研究
- 年轻人的健康年轻人的健康
背景情况:
- 由于医疗和非医疗原因,大麻的使用正在增加.
- 癌症幸存者,特别是年轻人,可能有独特的大麻使用情况.
- 有限的研究存在于年轻成年人的大麻使用与癌症史.
研究的目的:
- 对年轻有癌症史的成年人使用大麻的现有文献进行范围审查.
- 在这个人群中识别大麻使用的模式,动机和结果.
- 为了突出当前研究的差距.
主要方法:
- 在2024年10月在MEDLINE/PubMed进行了全面的文献搜索.
- 包括经验性,同行评审的英语文章,重点关注18-39岁的个体,先前有癌症诊断和大麻使用数据.
- 十五篇文章符合纳入标准,采用各种研究设计,包括横截面调查,纵向研究,观察研究和图表审查.
主要成果:
- 包括的研究因癌症诊断时间和参与者在数据收集时的年龄而异.
- 与同龄人相比,癌症幸存者中使用大麻的流行率显示出混合的结果.
- 医疗使用的动机包括症状管理 (恶心,疼痛,失眠,情绪),有一些有效性的证据.
结论:
- 现有的研究主要集中在癌症治疗期间的医用大麻使用上.
- 需要更多关于非医疗大麻使用和年轻成年幸存者的癌症治疗之外的使用的研究.
- 患有癌症史的年轻人可能会表现出不同的大麻使用行为,包括医疗和非医疗用途.
相关概念视频
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
367
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
367
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:19Psychoneuroimmunology: Diabetes and Cancer
62
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
62
02:18Cancer
49.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.6K
01:21Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455